Tsuguhide Takeshima

Tsuguhide Takeshima

UNVERIFIED PROFILE

Are you Tsuguhide Takeshima?   Register this Author

Register author
Tsuguhide Takeshima

Tsuguhide Takeshima

Publications by authors named "Tsuguhide Takeshima"

Are you Tsuguhide Takeshima?   Register this Author

16Publications

149Reads

41Profile Views

Rationale and evidence to combine radiation therapy and immunotherapy for cancer treatment.

Cancer Immunol Immunother 2017 Mar 14;66(3):281-298. Epub 2016 Oct 14.

Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, TX, 75390, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-016-1914-6DOI Listing
March 2017

Key role for neutrophils in radiation-induced antitumor immune responses: Potentiation with G-CSF.

Proc Natl Acad Sci U S A 2016 10 20;113(40):11300-11305. Epub 2016 Sep 20.

Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1613187113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056034PMC
October 2016

Real-time 4-D radiotherapy for lung cancer.

Cancer Sci 2012 Jan 14;103(1):1-6. Epub 2011 Nov 14.

Department of Radiation Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1349-7006.2011.02114.xDOI Listing
January 2012

Radiation-induced cancer cell repopulation: a possible mechanism implied by experiments using transplantable mouse-derived sarcoma cell line.

Cell Struct Funct 2011 25;36(1):13-20. Epub 2010 Dec 25.

Department of Biomedical Sciences and Engineering, Faculty of Health Science, Hokkaido University, N12-W5, Sapporo 060-0812, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1247/csf.10008DOI Listing
August 2011

Combination tumor immunotherapy with radiotherapy and Th1 cell therapy against murine lung carcinoma.

Clin Exp Metastasis 2007 25;24(7):533-40. Epub 2007 Jul 25.

Division of Immunoregulation, Section of Disease Control, Institute for Genetic Medicine, Hokkaido University, N-15, W-7, Kita-ku, Sapporo 060-0815, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10585-007-9090-xDOI Listing
January 2008

The critical role of type-1 innate and acquired immunity in tumor immunotherapy.

Cancer Sci 2004 Sep;95(9):697-703

Division of Immunoregulation, Institute for Genetic Medicine, Hokkaido University, Kita-ku, Sapporo 060-0815, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1349-7006.2004.tb03248.xDOI Listing
September 2004

NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by alpha-galactosylceramide in vivo.

Immunol Lett 2004 Aug;95(1):5-11

Division of Immunoregulation, Section of Disease Control, Institute for Genetic Medicine, Hokkaido University, N-15, W-7, Sapporo 060-0815, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.imlet.2004.04.012DOI Listing
August 2004

Critical role of the Th1/Tc1 circuit for the generation of tumor-specific CTL during tumor eradication in vivo by Th1-cell therapy.

Cancer Sci 2003 Oct;94(10):924-8

Division of Immunoregulation, Section of Disease Control, Institute for Genetic Medicine, Hokkaido University, Sapporo 060-0815, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1349-7006.2003.tb01377.xDOI Listing
October 2003

Successful elimination of memory-type CD8+ T cell subsets by the administration of anti-Gr-1 monoclonal antibody in vivo.

Cell Immunol 2003 Aug;224(2):98-105

Division of Immunoregulation, Section of Disease Control, Institute for Genetic Medicine, Hokkaido University, 060-0815, Hokkaido, Sapporo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cellimm.2003.08.009DOI Listing
August 2003